Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Monit SR 40mg tablets
0206010K0BEACAG
|
Monit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monit XL60 tablets
0206010K0BEADAE
|
Monit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monoclate-P 1,000unit inj vials
0211000I0BCAAAD
|
Monoclate-P | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Monoclate-P 250unit inj vials
0211000I0BCABAE
|
Monoclate-P | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Monoclate-P 500unit inj vials
0211000I0BCACAC
|
Monoclate-P | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Monocor 10mg tablets
0204000H0BBABAB
|
Monocor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Monocor 5mg tablets
0204000H0BBAAAA
|
Monocor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Mononine 1,000unit inj vials
0211000J0BEABAF
|
Mononine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Mononine 500unit inj vials
0211000J0BEAAAE
|
Mononine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Monoparin 1,000units/1ml solution for injection ampoules
0208010K0BCAAA7
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 10,000units/10ml solution for injection ampoules
0208010K0BCAGA2
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 20,000units/20ml solution for injection ampoules
0208010K0BCAHAZ
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 25,000units/1ml solution for injection ampoules
0208010K0BCAHBF
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 25,000units/5ml solution for injection ampoules
0208010K0BCAIBC
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 5,000units/0.2ml solution for injection ampoules
0208010K0BCAEAL
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 5,000units/1ml solution for injection ampoules
0208010K0BCABA9
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 5,000units/5ml solution for injection ampoules
0208010K0BCADA8
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin calcium 5,000units/0.2ml inj ampoules
0208010N0BEAAAB
|
Monoparin calcium | Heparin calcium | Cardiovascular System | No data available |
|
Monosorb XL 60 tablets (Teva)
0206010K0CCACAE
|
Monosorb | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monozide 10 tablets
020400090BBAAAA
|
Monozide 10 | Bisoprolol fumarate with diuretic | Cardiovascular System | No data available |
|
Moroctocog alfa 1,000unit inj pfs
0211000I0AAASAS
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 1,000unit inj vials
0211000I0AABBBB
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 2,000unit inj pfs
0211000I0AAAQAQ
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 2,000unit inj vials
0211000I0AAAZAZ
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 250unit inj pfs
0211000I0AAATAT
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.